EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, LungLife AI's enterprise value is £3.87 Mil.
LungLife AI's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was £0.04 Mil. Therefore, LungLife AI's EV-to-Revenue for today is 107.50.
The historical rank and industry rank for LungLife AI's EV-to-Revenue or its related term are showing as below:
LSE:LLAI'
s EV-to-Revenue Range Over the Past 10 Years
Min: -55.7 Med: 246.4 Max: 1046.4
Current: 107.5
During the past 6 years, the highest EV-to-Revenue of LungLife AI was 1046.40. The lowest was -55.70. And the median was 246.40.
LSE:LLAI's EV-to-Revenue is ranked worse than 96.4% of 222
companies
in the Medical Diagnostics & Research industry
Industry Median: 3.225
vs LSE:LLAI: 107.50
As of today (2024-05-27), LungLife AI's stock price is £0.19.
LungLife AI's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.00. Therefore, LungLife AI's PS Ratio for today is 95.00.
LungLife AI EV-to-Revenue Historical Data
The historical data trend for LungLife AI's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of LungLife AI's EV-to-Revenue
For the Diagnostics & Research subindustry, LungLife AI's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LungLife AI's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, LungLife AI's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where LungLife AI's EV-to-Revenue falls into.
LungLife AI's current Enterprise Value is £3.87 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. LungLife AI's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was £0.04 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LungLife AI's share price for today is £0.19.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was £0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LungLife AI EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of LungLife AI's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
LungLife AI Inc is a diagnostic company focused on the early detection of lung cancer from a simple blood draw enhanced by artificial intelligence. Its LungLB Test is a blood-based tool developed to provide clinicians the information needed to make informed decisions about the management of lung nodules and lung cancer.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:LLAI has been successfully added to your 